DSNKY Daiichi Sankyo Company, Limited (ADR) Loading...

Loading chart...
Top Calls
Feed
All Sources✓
YouTube✓
Twitter✓
Reddit✓
Substack✓
Insider✓
Loading...
0 selected
All directions✓
▲ Long✓
▼ Short✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
05:58
May 12
Hiroyuki Okuzawa President and CEO Bloomberg Markets
Strong product growth drives continued upside.
Daiichi Sankyo's flagship oncology products are growing strongly, with one expected to reach nearly 1 trillion yen in annual sales and another above 100 billion yen. Despite conservative guidance, the fundamental business is robust and will drive continued growth over the next five years.
DSNKY 1ST
HIGH

About DSNKY Analyst Coverage

Buzzberg tracks DSNKY (Daiichi Sankyo Company, Limited (ADR)) across 1 sources. 1 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 1 total trade ideas tracked.